Abstract

Staphylococcus aureus is a predominant cause of chronic lung infections. While the airway environment is rich in highly sialylated mucins, the interaction of S. aureus with sialic acid is poorly characterized. Using S. aureus USA300 as well as clinical isolates, we demonstrate that quorum-sensing dysfunction, a hallmark of S. aureus adaptation, correlates with a greater ability to consume free sialic acid, providing a growth advantage in an air-liquid interface model and in vivo. Furthermore, RNA-seq experiment reveals that free sialic acid triggers transcriptional reprogramming promoting S. aureus chronic lifestyle. To support the clinical relevance of our results, we show the co-occurrence of S. aureus, sialidase-producing microbiota and free sialic acid in the airway of patients with cystic fibrosis. Our findings suggest a dual role for sialic acid in S. aureus airway infection, triggering virulence reprogramming and driving S. aureus adaptive strategies through the selection of quorum-sensing dysfunctional strains.

This study by Ding et al reveals that the quorum-sensing dysfunction typically encountered in lung-adapted Staphylococcus aureus isolates could be selected by an enhanced ability to consume sialic acid released from airway mucins by the microbiota.

Details

Title
Airway environment drives the selection of quorum sensing mutants and promote Staphylococcus aureus chronic lifestyle
Author
Ding, Xiongqi 1   VIAFID ORCID Logo  ; Robbe-Masselot, Catherine 2 ; Fu, Xiali 1 ; Léonard, Renaud 2 ; Marsac, Benjamin 2 ; Dauriat, Charlene J. G. 3 ; Lepissier, Agathe 1 ; Rytter, Héloïse 1 ; Ramond, Elodie 4 ; Dupuis, Marion 1 ; Euphrasie, Daniel 1 ; Dubail, Iharilalao 1 ; Schimmich, Cécile 5 ; Qin, Xiaoquan 6 ; Parraga, Jessica 7 ; Leite-de-Moraes, Maria 1 ; Ferroni, Agnes 7 ; Chassaing, Benoit 3 ; Sermet-Gaudelus, Isabelle 1 ; Charbit, Alain 1   VIAFID ORCID Logo  ; Coureuil, Mathieu 1   VIAFID ORCID Logo  ; Jamet, Anne 8   VIAFID ORCID Logo 

 Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, Paris, France (GRID:grid.465541.7) (ISNI:0000 0004 7870 0410) 
 Université Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France (GRID:grid.503422.2) (ISNI:0000 0001 2242 6780) 
 INSERM U1016, CNRS UMR8104, Université Paris Cité, Team «Mucosal Microbiota in Chronic Inflammatory Diseases», Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602) 
 Genoscope, UMR8030, Laboratory of Systems & Synthetic Biology (LISSB), Xenome team, Evry, France (GRID:grid.434728.e) (ISNI:0000 0004 0641 2997) 
 Physiopathology and epidemiology of equine diseases (PhEED), RD 675, Anses, Laboratory of Animal Health in Normandy, Goustranville, France (GRID:grid.15540.35) (ISNI:0000 0001 0584 7022) 
 Université Paris Cité, Institut de physique du globe de Paris, CNRS, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602) 
 AP-HP Centre Université de Paris Cité, Department of Clinical Microbiology, Necker-Enfants Malades Hospital, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602) 
 Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, Paris, France (GRID:grid.465541.7) (ISNI:0000 0004 7870 0410); AP-HP Centre Université de Paris Cité, Department of Clinical Microbiology, Necker-Enfants Malades Hospital, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602) 
Pages
8135
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2899555620
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.